Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
22
Number of overlapping holdings
30.6%
% of CNCR's 72 holdings also in CANC
46.8%
% of CANC's 47 holdings also in CNCR
Overlap by Weight
Sector Drift (CNCR minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CNCR |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
EXELIXIS INC | 1.9% | 3.0% | 1.9% |
|
REVOLUTION MEDICINES, INC. | 1.8% | 4.6% | 1.8% |
|
SPRINGWORKS THERAPEUTICS, INC. | 1.6% | 2.4% | 1.6% |
|
ARCELLX, INC. | 1.6% | 1.6% | 1.6% |
|
BLUEPRINT MEDICINES CORP. | 1.6% | 4.3% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
CNCR Overweight Relative to CANC
|
RECURSION PHARMACEUTICALS, INC CLASS | 3.0% |
|
MONTE ROSA THERAPEUTICS, INC. | 2.6% |
|
IMMUNITYBIO INC | 2.0% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | 2.0% |
|
REPLIMUNE GROUP, INC. | 1.9% |
|
XENCOR INC | 1.7% |
|
BRISTOL-MYERS SQUIBB CO | 1.7% |
|
MERSANA THERAPEUTICS, INC. | 1.6% |
|
ZYMEWORKS INC. | 1.6% |
|
KARYOPHARM THERAPEUTICS INC | 1.6% |
CNCR Underweight Relative to CANC
|
GILEAD SCIENCES INC | -5.4% |
 |
ASTRAZENECA PLC | -5.2% |
|
REGENERON PHARMACEUTICALS | -4.5% |
 |
ARGENX SE ADR | -4.3% |
|
INCYTE CORP | -4.2% |
|
ILLUMINA INC | -3.8% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.3% |
|
DAIICHI SANKYO CO LTD | -3.1% |
|
AGIOS PHARMACEUTICALS INC | -2.9% |
|
BLUEPRINT MEDICINES CORP. | -2.8% |